Literature DB >> 11321581

Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.

K Poole1.   

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen characterized by an innate resistance to multiple antimicrobial agents. A major contribution to this intrinsic multidrug resistance is provided by a number of broadly-specific multidrug efflux systems, including MexAB-OprM and MexXY-OprM. In addition, these and two additional tripartite efflux systems, MexCD-OprJ and MexEF-OprN, promote acquired multidrug resistance as a result of mutational hyperexpression of the efflux genes. In addition to antibiotics, these pumps promote export of numerous dyes, detergents, inhibitors, disinfectants, organic solvents and homoserine lactones involved in quorum sensing. The efflux pump proteins are highly homologous and consist of a cytoplasmic membrane-associated drug-proton antiporter of the Resistance-Nodulation-Division (RND) family, an outer membrane channel-forming protein [sometimes called outer membrane factor (OMF)] and a periplasmic membrane fusion protein (MFP). Homologues of these systems have been described in Stenotrophomonas maltophilia, Burkholderia cepacia, Burkholderia pseudomallei and the non-pathogen Pseudomonas putida, where they play a role in export of and resistance to multiple antimicrobial agents and/or organic solvents. Although the natural function of these multidrug efflux systems is largely unknown, their contribution to antibiotic resistance and their conservation in a number of important human pathogens makes them logical targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11321581

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  145 in total

Review 1.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 2.  Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

Authors:  P A Lambert
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity.

Authors:  Lateef Adewoye; Ainsley Sutherland; Ramakrishnan Srikumar; Keith Poole
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

Review 4.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Structural insight into the oxidation-sensing mechanism of the antibiotic resistance of regulator MexR.

Authors:  Hao Chen; Chengqi Yi; Jin Zhang; Wenru Zhang; Zhiyun Ge; Cai-Guang Yang; Chuan He
Journal:  EMBO Rep       Date:  2010-07-09       Impact factor: 8.807

6.  mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol.

Authors:  Hossam Fetar; Christie Gilmour; Rachael Klinoski; Denis M Daigle; Charles R Dean; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

7.  HNP-3 enhanced the antimicrobial activity of CIP by promoting ATP efflux from P. aeruginosa cells.

Authors:  Hao Wang; Birong Dong; Li Lou
Journal:  Mol Biol Rep       Date:  2010-11-25       Impact factor: 2.316

8.  Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans.

Authors:  B Prithiviraj; H P Bais; T Weir; B Suresh; E H Najarro; B V Dayakar; H P Schweizer; J M Vivanco
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 9.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

10.  Lipopeptides produced by a soil Bacillus megaterium strain.

Authors:  Manuel Troyano Pueyo; Carlos Bloch; Ana Maria Carmona-Ribeiro; Paolo di Mascio
Journal:  Microb Ecol       Date:  2008-10-29       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.